Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide-Reference-Cited by-同舟云学术

Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide

Published:2014-12 Issue:6 Volume:113 Page:935-944
ISSN:0007-0912
Container-title:British Journal of Anaesthesia
language:en
Short-container-title:British Journal of Anaesthesia

Author:

Klimas R.,Mikus G.

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine

Link

http://academic.oup.com/bja/article-pdf/113/6/935/693310/aeu186.pdf

Reference76 articles.

1. Opioid pharmacology;Trescot;Pain Physician,2008

2. Morphine metabolites;Christrup;Acta Anaesthesiol Scand,1997

3. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations;Hasselstrom;Clin Pharmacokinet,1993

4. Morphine metabolism, transport and brain disposition;Gregori;Metab Brain Dis,2012

5. The pharmacokinetics of morphine and morphine glucuronides in kidney failure;Osborne;Clin Pharmacol Ther,1993

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotection by resveratrol-glucuronide and quercetin-glucuronide via binding to polyphenol- and glycosaminoglycan-binding sites in the laminin receptor;NEURAL REGEN RES;2025

2. The role of drug efflux and uptake transporters in the plasma pharmacokinetics and tissue disposition of morphine and its main metabolites;Toxicology and Applied Pharmacology;2024-09

3. PBPK-PD model for predicting morphine pharmacokinetics, CNS effects and naloxone antagonism in humans;Acta Pharmacologica Sinica;2024-04-03

4. Nalbuphine-6-glucuronide is a potent analgesic with superior safety profiles by altering binding affinity and selectivity for mu-/kappa-opioid receptors;Life Sciences;2024-03

5. Resveratrol and its metabolites elicit neuroprotection via high‐affinity binding to the laminin receptor at low nanomolar concentrations;FEBS Letters;2024-02-27